Abstract
Myocardial hypertrophy has been recognized to be an adaptive response to a variety of external stimuli (e.g., myocardial infarction, pressure overload, catecholamine treatment, endocrine disorders) that are involved in several subcellular factors that mediate signaling pathways, from external stimuli to nuclear protein synthesis. Glycogen synthase kinase-3β (GSK-3β) is one of the subcellular factors that regulate nuclear transcription factors, such as activated T-cell (NFAT) proteins, that are related to gene programming during cardiac hypertrophy. On the other hand, GSK-3β, known as a regulator of cardiomyocyte growth in Wnt signaling of cardiogenesis, is involved in β-catenin degradation. Inhibition of GSK-3β has been reported to induce cardiac hypertrophy. Tateishi et al. demonstrated in an aortic constriction-induced acute hypertrophy model using 6-week-old Wister rats that if GSK-3b is inhibited by LiCl up-regulated β-catenin expression and additional hypertrophy were observed. They suggested that Li2+ had an additive effect on pressure overload-induced hypertrophy through the GSK-3β—β-catenin pathway. Their article provides promising information on the mechanism of hypertrophic myocyte growth during acute pressure overload.
Article PDF
Avoid common mistakes on your manuscript.
References
Molkentin JD, Dorn GW. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Ann Rev Physiol 2001;63:391–426.
Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215–228.
Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, et al. Activity glycogen synthase-3b. suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 2002;99:907–912.
Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H, et al. Calcineuryn plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 1999;100:2449–2454.
Olsen EN, Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 2003;17:1937–1956.
Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, et al. Glycogen synthase kinase-3β. is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000;151:117–129.
Haq S, Michael A, Andreucci M, Bhattacharya, Dotto P, Walters B, et al. Stabilization of β-catenin by a Wntindependent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 2003;100:4610–4615.
Author information
Authors and Affiliations
Corresponding author
Additional information
This editorial refers to the article by Tateishi et al. on pp 265–270 of this issue of General Thoracic and Cardiovascular Surgery.
Rights and permissions
About this article
Cite this article
Yamamoto, F., Yamamoto, H. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload. Gen Thorac Cardiovasc Surg 58, 263–264 (2010). https://doi.org/10.1007/s11748-009-0562-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-009-0562-6